MJSC yields 0.62% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, MJSC + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MJSC + MRK for your $10,000?
MJSC invests in small-cap Japanese companies with pioneering business models, strong competitive positions, capable management, and attractive valuations. The portfolio includes common and preferred stocks, depositary receipts, REITs, IPOs, and ETFs. Stock selection follows a thematic process, combining quantitative screens and proprietary supply chain analysis to identify early-stage, high-growth companies positioned for structural and cyclical trends. The strategy seeks to capitalize on inefficiencies in Japan's under-researched small-cap market. While focused on Japan, the fund may allocate up to 20% of assets to companies outside Japan, including both emerging and developed markets. Up to one-third of the portfolio may be lent with collateral safeguards to generate additional income. Positions are actively monitored, with sales initiated when growth prospects weaken or valuations become stretched.
Full MJSC Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.